Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
基本信息
- 批准号:7922796
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-29 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAgonistAmino Acid SequenceAnesthesia proceduresAnestheticsBreathingBronchodilationCellsChemosensitizationClinicalConsciousCoupledDevelopmentElectrodesElectrophysiology (science)ExhibitsFacultyGeneral AnesthesiaGeneral HospitalsGeneral anesthetic drugsHalothaneHypoxiaInbred F344 RatsIon ChannelIsofluraneKnowledgeLeadMammalian CellMediatingMemoryMethodsMolecularMolecular Biology TechniquesMuscarinicsMuscle TonusNervous system structureNeuraxisNeurosciencesPeripheralPharmaceutical PreparationsPharmacologyPotassiumPotassium ChannelPrincipal InvestigatorProgram DevelopmentProteinsPublic HealthRNA InterferenceReceptor ActivationReceptor InhibitionRegulationResearchResearch PersonnelResistanceRoleSignaling ProteinSiteSite-Directed MutagenesisSmooth MuscleTestingThyroid GlandTissuesTraining ProgramsVasodilationWakefulnessWorkXenopus oocytebasecell typeclinically relevantdepresseddesfluranemedical schoolsmembermutantnovelpatch clampprogramsreceptor couplingreceptor functionreconstitutionresponsesevofluraneskillsvoltage clamp
项目摘要
This proposal describes a 5-year training program for the development of an independent investigator in
volatile anesthetic mechanisms. The principal investigator is a faculty member in the Department of
Anesthesia, Harvard Medical School, with a background in electrophysiology,who will acquire new
knowledge and skills in neuroscience and pharmacology sufficient to lead his own independent research
program. Work will be conducted in the Mallinckrodt Pharmacology Research Unit at Massachussets
General Hospital which focuses on volatile anesthetic mechanisms. ;
Our SPECIFIC AIMS wil test the novel hypothesis that volatile anesthetics potentiate TASK-3 function
indirectly by inhibition of basal or agonst-mediated Galpha-q protein coupled receptor (GqPCR) activity. The
TASK-3 tandem pore potassium channel is a volatile anesthetic-potentiated and pH- and hypoxia-inhibited
ion channel. TASK-3 is widely expressed in the central nervous system and in peripheral tissue and has a
role in chemosensing in a variety of cell types, including those involved in regulation of breathing. TASK-3
function is also inhibited by GqPCR activation. GqPCRs in the CNS regulate memory, wakefulness, and
consciousness and peripherally are important regulators of smooth muscle tone. The function of many
GqPCRs are inhibited by volatile anesthetics. To test our hypothesis we will use two-electrode voltage
clamp of Xenopus oocytes or Ussing Chamber studies of Fischer Rat Thyroid cells heterologously
expressing TASK-3 channels and ml or m3 GqPCRs and Galpha-q protein. We will also employ the excised
patch-clamp method, and several molecular biology techniques including RNA interference and site-directed
mutagenesis. LONG TERM GOALS: This project will clairfy the molecular mechanism by which volatile
anesthetics potentiate TASK channels. RELEVANCE TO PUBLIC HEALTH: This work will help establish
principles to guide development of safer anesthetic drugs that do not effect breathing and further elucidate
the mechanism by which these drugs induce anesthesia. i
该提案描述了一项为期5年的培训计划,以开发独立研究者
挥发性麻醉机制。首席调查员是部门的教职员工
麻醉,哈佛医学院,具有电生理学背景,他将获得新的
神经科学和药理学方面的知识和技能足以领导自己的独立研究
程序。工作将在马萨诸塞州的Mallinckrodt药理学研究部门进行
综合医院专注于挥发性麻醉机制。 ;
我们的具体目的将检验一个新的假设,即挥发性麻醉剂增强了任务-3功能
通过抑制基础或Agonst介导的Galpha-Q蛋白偶联受体(GQPCR)活性间接地。这
Task-3串联孔钾通道是一种挥发性麻醉症,抑制pH和缺氧
离子通道。任务3在中枢神经系统和周围组织中广泛表达,具有
在各种细胞类型中的化学相变中的作用,包括参与呼吸调节的细胞。任务3
GQPCR激活也抑制了功能。中枢神经系统中的GQPCR调节记忆,清醒和
意识和外围是平滑肌音调的重要调节因子。许多功能
GQPCR被挥发性麻醉剂抑制。为了检验我们的假设,我们将使用两电极电压
异植型卵母细胞的夹具或Fischer大鼠甲状腺细胞的室内研究
表达任务3通道以及ML或M3 GQPCR和Galpha-Q蛋白。我们还将采用切除的
斑块钳法和几种分子生物学技术,包括RNA干扰和位置定向
诱变。长期目标:这个项目将使挥发性的分子机制保持紧张
麻醉剂增强任务渠道。与公共卫生有关:这项工作将有助于建立
指导不影响呼吸并进一步阐明的安全麻醉药物开发的原则
这些药物诱导麻醉的机制。我
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph F Cotten其他文献
Joseph F Cotten的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph F Cotten', 18)}}的其他基金
Anesthetic activation of TASK-3 tandem pore potassium channels: molecular mechanisms and behavioral effects
TASK-3串联孔钾通道的麻醉激活:分子机制和行为效应
- 批准号:
9900029 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
9264573 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
8843947 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
9058592 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
8478315 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
8665480 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
7530533 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
7681262 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
7924160 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
8320182 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
- 批准号:82372196
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuity
了解芳烃受体混杂的起源和机制
- 批准号:
10679532 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Deciphering the complex pharmacology of CB1: towards the understanding of a third signaling pathway
解读 CB1 的复杂药理学:了解第三条信号通路
- 批准号:
10667865 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Engineering an intranasal universal influenza vaccine
设计鼻内通用流感疫苗
- 批准号:
9526306 - 财政年份:2017
- 资助金额:
$ 10.8万 - 项目类别:
Cannabinoid Receptors and Associated Proteins-Renewal
大麻素受体和相关蛋白质更新
- 批准号:
10657170 - 财政年份:2017
- 资助金额:
$ 10.8万 - 项目类别:
Novel opioid peptides for nose to brain delivery
用于鼻子到大脑输送的新型阿片肽
- 批准号:
9335835 - 财政年份:2016
- 资助金额:
$ 10.8万 - 项目类别: